We are live on
!
Find out more
ED
Exane Derivatives Portfolio holdings
AUM
$174M
1-Year Est. Return
7.84%
This Fund
S&P 500
This Quarter
Est. Return
+1.06%
1 Year Est. Return
-7.84%
3 Year Est. Return
+42.72%
5 Year Est. Return
+56.28%
10 Year Est. Return
–
AUM
$355M
AUM Growth
-$58.3M
(-14%)
Cap. Flow
-$49.6M
Cap. Flow
% of AUM
-13.96%
Top 10 Holdings %
Top 10 Hldgs %
19.68%
Holding
1,105
New
222
Increased
181
Reduced
330
Closed
90
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares MSCI China ETF
MCHI
|
+$5.54M |
| 2 |
iShares MSCI Global Metals & Mining Producers ETF
PICK
|
+$4.8M |
| 3 |
Visa
V
|
+$4.5M |
| 4 |
Zoetis
ZTS
|
+$2.31M |
| 5 |
Wells Fargo
WFC
|
+$2.29M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Stellantis
STLA
|
+$24.9M |
| 2 |
Ferrari
RACE
|
+$19.1M |
| 3 |
CNH
CNH Industrial
CNH
|
+$12.3M |
| 4 |
iShares S&P 500 Value ETF
IVE
|
+$8.23M |
| 5 |
UBS Group
UBS
|
+$5.09M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 18.09% |
| 2 | Technology | 16.07% |
| 3 | Consumer Discretionary | 9.4% |
| 4 | Healthcare | 9.16% |
| 5 | Industrials | 8.21% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
476
Fastly Inc
FSLY
$3.75B
| $97.2K | 0.03% |
5,591
-3,744
| -40% | -$87.4K |
|
477
Xylem
XYL
$25B
| $96.2K | 0.03% |
+1,128
| New | +$108K |
|
478
Root
ROOT
$812M
| $94.8K | 0.03% |
2,674
-300
| -10% | -$10.8K |
|
479
Kiniksa Pharmaceuticals
KNSA
$6.06B
| $94.4K | 0.03% |
9,496
-811
| -8% | -$8.59K |
|
|
NREF
480
NexPoint Real Estate Finance
NREF
$301M
| $93.9K | 0.03% |
4,155
-1,525
| -27% | -$31.8K |
|
|
BLDP
481
Ballard Power Systems
BLDP
$633M
| $93.9K | 0.03% |
8,065
-196
| -2% | -$2.09K |
|
|
KRTX
482
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
| $93.8K | 0.03% |
740
-63
| -8% | -$7.09K |
|
483
Autodesk
ADSK
$46B
| $93.2K | 0.03% |
435
-523
| -55% | -$120K |
|
484
Etsy
ETSY
$6.74B
| $92.3K | 0.03% |
743
-111
| -13% | -$16.5K |
|
485
NXP Semiconductors
NXPI
$55.2B
| $91.1K | 0.03% |
492
+271
| +123% | +$53.4K |
|
486
Medifast
MED
$134M
| $89.5K | 0.03% |
524
-107
| -17% | -$20.2K |
|
487
Neogen
NEOG
$2.74B
| $87.6K | 0.02% |
2,841
-575
| -17% | -$20.7K |
|
488
iShares Russell 2000 ETF
IWM
$76.5B
| $87.2K | 0.02% |
425
-1,211
| -74% | -$247K |
|
489
State Street SPDR S&P Biotech ETF
XBI
$10.4B
| $86.5K | 0.02% |
963
| – | – |
|
|
BBIG
490
DELISTED
Vinco Ventures, Inc. Common Stock
BBIG
| $85.2K | 0.02% |
+1,958
| New | +$78.1K |
|
491
UnitedHealth
UNH
$337B
| $85.2K | 0.02% |
+167
| New | +$80.5K |
|
492
Viking Therapeutics
VKTX
$3.44B
| $83.3K | 0.02% |
+27,776
| New | +$99.6K |
|
493
Veeva Systems
VEEV
$42.9B
| $83.1K | 0.02% |
+391
| New | +$84.8K |
|
494
Freshpet
FRPT
$2.98B
| $82.6K | 0.02% |
805
-161
| -17% | -$15.2K |
|
495
Packaging Corp of America
PKG
$20.6B
| $82.1K | 0.02% |
+526
| New | +$76.8K |
|
|
DSL
496
DoubleLine Income Solutions Fund
DSL
$1.17B
| $81.5K | 0.02% |
5,612
-525
| -9% | -$7.91K |
|
497
Agnico Eagle Mines
AEM
$99B
| $81K | 0.02% |
1,324
+341
| +35% | +$18.5K |
|
498
Phathom Pharmaceuticals
PHAT
$622M
| $79.9K | 0.02% |
5,874
+816
| +16% | +$13.2K |
|
499
International Paper
IP
$18B
| $79.6K | 0.02% |
1,724
+1,701
| +7,396% | +$78.3K |
|
|
WIMI
500
WiMi Hologram Cloud
WIMI
$18.9M
| $79.5K | 0.02% |
+2,979
| New | +$80.2K |
|
Similar funds
PC
TWMP
LPWM
ACM
HWIS
LWM
EW
GDWAM
Exane Derivatives's Q1 2022 Portfolio in Review
As of Q1 2022, Exane Derivatives held 1,105 positions worth $355M, down 14% from $413M the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Exane Derivatives withdrew a net $49.6M in Q1 2022, closing 90 positions and reducing 330 holdings. Its most notable exit was iShares S&P 500 Value ETF, an estimated $8.23M position sold in full.
By sector, the portfolio is most concentrated in Miscellaneous at 18% of assets, up from 15% a quarter earlier, followed by Technology and Consumer Discretionary.
Against the trend, Exane Derivatives opened a new position in Visa worth $4.62M.
- Exane Derivatives's largest Q1 2022 buy was Visa: 20,811 shares worth $4.62M.
- Exane Derivatives added most to iShares MSCI China ETF in Q1 2022, an estimated $5.54M increase.
- Exane Derivatives's biggest Q1 2022 reduction was Stellantis, cutting an estimated $24.9M.
- Exane Derivatives fully exited iShares S&P 500 Value ETF in Q1 2022, selling an estimated $8.23M.
- Exane Derivatives's ten largest holdings make up 20% of its $355M portfolio in Q1 2022.
- Exane Derivatives opened 222 new positions and closed 90 in Q1 2022.
- Exane Derivatives's portfolio value fell 14% quarter-over-quarter to $355M.
Based on Exane Derivatives's 13F filing for Q1 2022, filed 22 Apr 2022.